The effort, which relied on Oxford BioDynamics' EpiSwitch platform, resulted in an assay that researchers believe could be developed into a test to guide therapy selection for patients.
The Guardian reports that labs in the UK have had safety incidents involving pathogens.
Salmon with shorter telomeres survive to make the trip back to their river homes, New Scientist reports.
The University of Edinburgh analyzed more than 6,000 genomes in a year, an effort made possible by a computing center dubbed a "genome factory" by its director.
Researchers profiling pancreatic neuroendocrine tumors detected inherited cancer-related mutations in nearly one-fifth of affected individuals.
The Stoller Biomarker Discovery Centre, funded by the UK's Medical Research Council, recently opened to develop mass spec-based research for varied diseases.
The node will act as a center for molecular diagnostics research, discovery, and development, and will integrate with existing initiatives.
Using genomic and other technologies, researchers will develop tools to identify HAIs, identify patients at risk for them, and investigate more effective use of antibiotics.
The universities are partnering with Illumina to supply next-generation sequencing instruments to drive research in cancer, personalized medicine, and agriculture.
NEW YORK (GenomeWeb News) – The University of Glasgow said yesterday it will use £3 million ($5 million) from the Scottish government to support a new imaging center and stratified medicine clinical research program.
Sometimes genetic tests give inconclusive results and provide little reassurance to patients, the Associated Press reports.
Vox wonders whether gene-editing crops will be viewed similarly as genetically modified organisms of if people will give them a try.
In Science this week: research regulation and reporting requirement reform, and more.
With H3Africa, Charles Rotimi has been working to bolster the representation of African participants and African researchers in genomics, Newsweek reports.